HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schnyder, B. Articles by Pichler, W. J. Search for Related Content PubMed PubMed Citation Articles by Schnyder, B. Articles by Pichler, W. J.

Recognition of Sulfamethoxazole and Its Reactive Metabolites by Drug-Specific CD4⁺ T Cells from Allergic Individuals¹

Benno Schnyder^2,3,*, Christoph Burkhart^3,*, Karin Schnyder-Frutig^*, Salome von Greyerz^*, Dean J. Naisbitt, Munir Pirmohamed, B. Kevin Park and Werner J. Pichler^4,*

^* Clinic of Rheumatology and Clinical Immunology/Allergology, Inselspital, Bern, Switzerland; and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom

The recognition of the antibiotic sulfamethoxazole (SMX) by T cells is usually explained with the hapten-carrier model. However, recent investigations have revealed a MHC-restricted but processing- and metabolism-independent pathway of drug presentation. This suggested a labile, low-affinity binding of SMX to MHC-peptide complexes on APC. To study the role of covalent vs noncovalent drug presentation in SMX allergy, we analyzed the proliferative response of PBMC and T cell clones from patients with SMX allergy to SMX and its reactive oxidative metabolites SMX-hydroxylamine and nitroso-SMX. Although the great majority of T cell clones were specific for noncovalently bound SMX, PBMC and a small fraction of clones responded to nitroso-SMX-modified cells or were cross-reactive. Rapid down-regulation of TCR expression in T cell clones upon stimulation indicated a processing-independent activation irrespective of specificity for covalently or noncovalently presented Ag. In conclusion, our data show that recognition of SMX presented in covalent and noncovalent bound form is possible by the same TCR but that the former is the exception rather than the rule. The scarcity of cross-reactivity between covalently and noncovalently bound SMX suggests that the primary stimulation may be directed to the noncovalently bound SMX.

This article has been cited by other articles:

				L. Cheng, B. J. Stewart, Q. You, D. R. Petersen, J. A. Ware, J. R. Piccotti, T. T. Kawabata, and C. Ju Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo Mol. Pharmacol., June 1, 2008; 73(6): 1769 - 1775. [Abstract] [Full Text] [PDF]

				J. P. Sanderson, D. J. Naisbitt, J. Farrell, C. A. Ashby, M. J. Tucker, M. J. Rieder, M. Pirmohamed, S. E. Clarke, and B. K. Park Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling J. Immunol., May 1, 2007; 178(9): 5533 - 5542. [Abstract] [Full Text] [PDF]

				D. A. Schmid, J. P. H. Depta, M. Luthi, and W. J. Pichler Transfection of Drug-Specific T-Cell Receptors into Hybridoma Cells: Tools to Monitor Drug Interaction with T-Cell Receptors and Evaluate Cross-Reactivity to Related Compounds Mol. Pharmacol., July 1, 2006; 70(1): 356 - 365. [Abstract] [Full Text] [PDF]

				D. J. Naisbitt, J. Farrell, P. J. Chamberlain, J. E. Hopkins, N. G. Berry, M. Pirmohamed, and B. K. Park Characterization of the T-Cell Response in a Patient with Phenindione Hypersensitivity J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1058 - 1065. [Abstract] [Full Text] [PDF]

				J. A. Wijsman, G. A. Dekaban, and M. J. Rieder Differential Toxicity of Reactive Metabolites of Clindamycin and Sulfonamides in HIV-Infected Cells: Influence of HIV Infection on Clindamycin Toxicity In Vitro J. Clin. Pharmacol., March 1, 2005; 45(3): 346 - 351. [Abstract] [Full Text] [PDF]

				A. M. Martin, D. Nolan, S. Gaudieri, C. A. Almeida, R. Nolan, I. James, F. Carvalho, E. Phillips, F. T. Christiansen, A. W. Purcell, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant PNAS, March 23, 2004; 101(12): 4180 - 4185. [Abstract] [Full Text] [PDF]

				W. J. Pichler Delayed Drug Hypersensitivity Reactions Ann Intern Med, October 21, 2003; 139(8): 683 - 693. [Abstract] [Full Text] [PDF]

				J. Farrell, D. J. Naisbitt, N. S. Drummond, J. P. H. Depta, F. J. Vilar, M. Pirmohamed, and B. K. Park Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 229 - 237. [Abstract] [Full Text] [PDF]

				D. J. Naisbitt, J. Farrell, S. F. Gordon, J. L. Maggs, C. Burkhart, W. J. Pichler, M. Pirmohamed, and B. K. Park Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Leads to Toxicity and Major Histocompatibility Complex-Restricted Antigen Presentation Mol. Pharmacol., September 1, 2002; 62(3): 628 - 637. [Abstract] [Full Text] [PDF]